novartis

The Ripple Effect: Investing in Life Sciences | Episode 2: How life sciences investment drives economic growth | GZERO Blue Circle x Novartis

The Ripple Effect: Investing in Life Sciences

How life sciences investment drives economic growth

In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.

The Ripple Effect: Investing in Life Sciences | Episode 1: Why life sciences are critical to national security | GZERO Blue Circle x Novartis

The Ripple Effect: Investing in Life Sciences

Why life sciences are critical to national security

What if the next virus isn’t natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the premiere episode of “The Ripple Effect: Investing in Life Sciences”, leading experts explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance.

The UN at a crossroads, with Secretary-General António Guterres

GZERO World with Ian Bremmer Podcast

The UN at a crossroads, with Secretary-General António Guterres

This year’s UN General Assembly took place against a backdrop of escalating conflict, fears of runaway AI, and deep divisions over international cooperation. UN Secretary-General António Guterres reflects on the UN’s role at a moment of great global uncertainty.